Apexium Financial’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$943K Sell
6,134
-223
-4% -$34.8K 0.05% 137
2025
Q2
$1.01M Sell
6,357
-12
-0.2% -$1.96K 0.05% 127
2025
Q1
$1.09M Buy
6,369
+1,547
+32% +$259K 0.06% 115
2024
Q4
$808K Buy
4,822
+931
+24% +$159K 0.05% 121
2024
Q3
$674K Buy
3,891
+98
+3% +$16.6K 0.04% 118
2024
Q2
$626K Buy
3,793
+344
+10% +$56.2K 0.04% 122
2024
Q1
$560K Sell
3,449
-2,689
-44% -$422K 0.04% 126
2023
Q4
$900K Buy
6,138
+2,281
+59% +$338K 0.06% 124
2023
Q3
$563K Sell
3,857
-199
-5% -$30.4K 0.06% 122
2023
Q2
$616K Buy
4,056
+611
+18% +$92.1K 0.05% 121
2023
Q1
$512K Buy
3,445
+1
+0% +$143 0.05% 129
2022
Q4
$522K Sell
3,444
-397
-10% -$55.7K 0.05% 129
2022
Q3
$485K Buy
+3,841
New +$546K 0.06% 124
2020
Q1
Sell
-2,017
Closed -$252K 76
2019
Q4
$252K Buy
+2,017
New +$247K 0.33% 56

Other funds holding PG

Apexium Financial's PG Position: Q3 2025 in Review

Apexium Financial reduced its Procter & Gamble (PG) stake by 3.5% in Q3 2025, selling an estimated $34.8K and leaving 6,134 shares worth $943K. The position accounts for 0.05% of the portfolio, ranked #137.

Apexium Financial first reported a position in PG in Q4 2019 and has held it in 14 quarters since. The position peaked at $1.09M in Q1 2025. 3,892 funds tracked by Wall St. Rank hold PG as of Q3 2025.

  • Apexium Financial held 6,134 shares of Procter & Gamble worth $943K as of Q3 2025.
  • Apexium Financial sold 223 Procter & Gamble shares in Q3 2025, an estimated $34.8K.
  • Procter & Gamble made up 0.05% of Apexium Financial's portfolio in Q3 2025, its #137 holding.
  • Apexium Financial first reported a position in Procter & Gamble in Q4 2019 and has held it in 14 quarters since.
  • Apexium Financial's Procter & Gamble position peaked at $1.09M in Q1 2025.
  • 3,892 funds tracked by Wall St. Rank held Procter & Gamble as of Q3 2025.

Based on Apexium Financial's 13F filing for Q3 2025, filed 18 Nov 2025.